Julian N. Stern
Keine laufenden Positionen mehr
Profil
Julian N.
Stern served as Chairman of Pherin Pharmaceuticals, Inc. for 27 years until 2018.
He also held positions as Director & Secretary at ALZA Corp., Affymax NV, and Cetus Corp.
Additionally, he served as Secretary & Director at Assertio Therapeutics, Inc. for 18 years until 2013.
Stern was also Secretary at Heron Therapeutics, Inc. and ROXRO Pharma, Inc. Furthermore, he was a Partner & Senior Counsel at Heller Ehrman LLP and Counsel at Goodwin Procter LLP.
Stern served as Secretary at FibroGen, Inc. until 2018 and is currently a Trustee at Peter A.
& Vernice H.
Gasser Foundation.
Stern received his undergraduate degree from New York University in 1946 and his graduate degree from Yale Law School.
Ehemalige bekannte Positionen von Julian N. Stern
| Unternehmen | Position | Ende |
|---|---|---|
| FIBROGEN, INC. | Direktor/Vorstandsmitglied | 07.06.2017 |
Pherin Pharmaceuticals, Inc.
 Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Vorsitzender | 24.05.2018 |
| Peter A. & Vernice H. Gasser Foundation | Direktor/Vorstandsmitglied | 24.05.2018 |
| Ronald & Ann Williams Charitable Foundation | Vorsitzender | 24.05.2018 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Direktor/Vorstandsmitglied | 15.05.2013 |
Ausbildung von Julian N. Stern
| New York University | Undergraduate Degree |
| Yale Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Heller Ehrman LLP
 Heller Ehrman LLP Miscellaneous Commercial ServicesCommercial Services Heller Ehrman LLP provides legal services. It offers litigation, business, and intellectual property services. The company was founded in 1980 and is headquartered in San Francisco, CA. | Commercial Services |
ROXRO Pharma, Inc.
 ROXRO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ROXRO Pharma, Inc. develops hospital strength acute pain products. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine; and SPRIX nasal spray for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level. The company was founded by Michael E Fitzgerald, Roger Whiting and Roberto Pedro Rosenkranz in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Finance |
| Affymax NV | Health Technology |
| Cetus Corp. | Health Technology |
Pherin Pharmaceuticals, Inc.
Pherin Pharmaceuticals, Inc. BiotechnologyHealth Technology Pherin Pharmaceuticals, Inc. operates as a clinical stage company. It focuses on the development of its proprietary compounds pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions. The firm’s products include Aloradine, PH10, Salubrin-HF and PH15. The company was founded in 1991 and is headquartered in Los Altos, CA. | Health Technology |
| Peter A. & Vernice H. Gasser Foundation | |
| Ronald & Ann Williams Charitable Foundation |
